Projects per year
Personal profile
Biography
The focus of the group is to identify essential, drugable cellular and biochemical pathways in microbial pathogens using small-molecule inhibitors known to kill the microorganism selectively.
I am a 'Fundamental Biology' graduate (with Honours in the UK system) from the Universidad Complutense of Madrid. My graduation thesis was on the biosynthesis of phospholipids in lung microsomes. Then I moved forever into Microbiology and anti-microbials.
I worked on bacteriocins for my Ph.D. at the Universidad Autonoma of Madrid and in the structure of the bacterial cell wall and the mode of action of beta-lactam antibiotics for four years while a Fulbright fellow at The Rockefeller University in New York. An EMBO fellowship brought me back to Europe to learn Eukaryotic (fungal) microbiology and genetics at the Biozentrum of Basel University in Switzerland, where I worked on nuclear protein transport in yeast for six years.
Then I joined the antifungal RandD centre in what was then the Glaxo pharmaceutical company in Tres Cantos, near Madrid, to lead the target identification group. As Glaxo morphed into GlaxoWellcome and then into today's GlaxoSmithKline, my responsibilities increased and included Biosafety.
The therapeutic area also changed consecutively to antibacterials and neglected infectious diseases (malaria and TB), ending with the leadership of the company's drug discovery effort in malaria. After sixteen years in industry I went back to academic life at Monash University, where I hope to address what is for me an important question arising from the drug discovery work but of no short-term interest to industry, namely whether the tens of thousands of potent anti-malarial compounds we discovered and published can be used to identify all the drug targets in the malaria parasite likely to result in a therapeutic effect, and their essential role in the parasite biology.
Along the way, we are enjoying the discovery of intriguing aspects in the cell division mechanism of this ancient pathogen.
Network
Projects
- 1 Finished
-
Class II/A Biosafety Cabinet
Trustee for Harold and Cora Brennen Benevolent Trust
7/10/14 → 7/10/15
Project: Research
Research output
-
Interaction of Plasmodium falciparum casein kinase 1 with components of host cell protein trafficking machinery
Batty, M. B., Schittenhelm, R. B., Dorin-Semblat, D., Doerig, C. & Garcia-Bustos, J. F., Jun 2020, In : IUBMB Life. 72, 6, p. 1243-1249 7 p.Research output: Contribution to journal › Article › Research › peer-review
-
Synthesis and structure-activity relationship study of pyrrolidine-oxadiazoles as anthelmintics against Haemonchus contortus
Ruan, B., Zhang, Y., Tadesse, S., Preston, S., Taki, A. C., Jabbar, A., Hofmann, A., Jiao, Y., Garcia-Bustos, J., Harjani, J., Le, T. G., Varghese, S., Teguh, S., Xie, Y., Odiba, J., Hu, M., Gasser, R. B. & Baell, J., 15 Mar 2020, In : European Journal of Medicinal Chemistry. 190, 8 p., 112100.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Synthetic kavalactone analogues with increased potency and selective anthelmintic activity against larvae of haemonchus contortus in vitro
Dilrukshi Herath, H. M. P., Taki, A. C., Nguyen, N., Garcia-Bustos, J., Hofmann, A., Wang, T., Ma, G., Chang, B. C. H., Jabbar, A., Sleebs, B. E. & Gasser, R. B., 24 Apr 2020, In : Molecules. 25, 8, 8 p., 2004.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile1 Citation (Scopus) -
An appraisal of natural products active against parasitic nematodes of animals
Garcia-Bustos, J. F., Sleebs, B. E. & Gasser, R. B., 17 Jun 2019, In : Parasites & Vectors. 12, 1, 22 p., 306.Research output: Contribution to journal › Review Article › Research › peer-review
Open AccessFile9 Citations (Scopus) -
Anti-Helicobacter pylori activity of ethoxzolamide
Modak, J. K., Tikhomirova, A., Gorrell, R. J., Rahman, M. M., Kotsanas, D., Korman, T. M., Garcia-Bustos, J., Kwok, T., Ferrero, R. L., Supuran, C. T. & Roujeinikova, A., 1 Dec 2019, In : Journal of Enzyme Inhibition and Medicinal Chemistry. 34, 1, p. 1660-1667 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile10 Citations (Scopus)